Coronary artery disease progression assessed by electron-beam computed tomography.

The ability to observe changes in atherosclerotic plaque burden over time should provide an accurate measure of efficacy for different cardiovascular therapies. Electron-beam computed tomography (EBCT), by quantification of coronary artery calcification, is a noninvasive measure of atherosclerosis burden. This article summarizes data from abstracts and publications related to coronary artery calcium measurement and its use in progression studies. The issues related to interscan variability and reproducibility of this measure are detailed. The limitations of multidetector spiral computed tomography (high radiation dose and poor reproducibility) are also addressed. Several studies of progression using 2 scans, administered > or =1 year apart, demonstrate significant annual progression (22% to 52% per year). All studies demonstrate that therapy with cholesterol-lowering agents slows the atherosclerotic process, and that it may lead to regression of coronary calcium over time. There are 2 small prognostic studies that demonstrate that coronary events predominantly occur in those patients who exhibit significant progression of coronary artery calcium. Large multicenter trials are underway to evaluate the prognostic significance of coronary artery calcium progression. The progression of coronary artery atherosclerosis can be observed noninvasively by monitoring the progression of coronary calcification with EBCT. With annual progression rates of 22% to 52% and a median interscan variability of only 5% to 8%, this technology provides an opportunity to noninvasively monitor patients to assess the clinical efficacy of medical therapies in studies as short as 1 year.

[1]  W. Edwards,et al.  Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. , 1998, Journal of the American College of Cardiology.

[2]  W. Janowitz,et al.  Comparison of serial quantitative evaluation of calcified coronary artery plaque by ultrafast computed tomography in persons with and without obstructive coronary artery disease. , 1991, The American journal of cardiology.

[3]  W Moshage,et al.  In-plane coronary arterial motion velocity: measurement with electron-beam CT. , 2000, Radiology.

[4]  M. Budoff,et al.  Rates of progression of coronary calcium by electron beam tomography. , 2000, The American journal of cardiology.

[5]  T. Callister,et al.  Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. , 1998, The New England journal of medicine.

[6]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[7]  C. Mielke,et al.  Reliability of electron beam computed tomography to detect coronary artery calcification. , 1995, American journal of cardiac imaging.

[8]  L. Bielak,et al.  Progression of coronary artery calcification: a pilot study. , 1999, Mayo Clinic proceedings.

[9]  H. Mabuchi,et al.  Quantification of coronary artery calcification using ultrafast computed tomography: Reproducibility of measurements , 1993, Coronary artery disease.

[10]  M. Reiser,et al.  Helical and single-slice conventional CT versus electron beam CT for the quantification of coronary artery calcification. , 2000, AJR. American journal of roentgenology.

[11]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[12]  Stanley Azen,et al.  Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS) , 1993, Annals of Internal Medicine.

[13]  M. Bell,et al.  Outcome > or = 10 years after successful percutaneous transluminal coronary angioplasty. , 1997, American Journal of Cardiology.

[14]  M. Leon,et al.  Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. , 1997, Journal of the American College of Cardiology.

[15]  R. Detrano,et al.  Detection of coronary calcification with electron-beam computed tomography: evaluation of interexamination reproducibility and comparison of three image-acquisition protocols. , 1996, American heart journal.

[16]  J. Mehta,et al.  Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. , 1996, American heart journal.

[17]  S. Achenbach,et al.  Variability of repeated coronary artery calcium measurements by electron beam tomography. , 2001, The American journal of cardiology.

[18]  M. Budoff,et al.  Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons. , 2001, International journal of cardiology.

[19]  L. Bielak,et al.  Coronary artery calcification measured at electron-beam CT: agreement in dual scan runs and change over time. , 2001, Radiology.

[20]  J G Goldin,et al.  Coronary artery calcium: alternate methods for accurate and reproducible quantitation. , 1997, Academic radiology.

[21]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[22]  M. Budoff,et al.  Coronary Artery Motion During the Cardiac Cycle and Optimal ECG Triggering for Coronary Artery Imaging , 2001, Investigative radiology.

[23]  S. Ellis,et al.  Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. , 1995, Journal of the American College of Cardiology.

[24]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[25]  M. Budoff,et al.  Coronary artery motion in electron beam tomography. , 2000, Journal of computer assisted tomography.

[26]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[27]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[28]  T. Callister,et al.  Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.

[29]  C. Furberg,et al.  Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. , 1995, Circulation.

[30]  M. Budoff,et al.  Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. , 1996, Circulation.

[31]  M. Rath,et al.  Nutritional Supplement Program Halts Progression of Early Coronary Atherosclerosis Documented by Ultrafast Computed Tomography , 1996 .

[32]  M. Budoff,et al.  Rates of progression of coronary calcification by electron beam computed tomography , 1999 .

[33]  M. Budoff,et al.  Effect of electrocardiogram triggering on reproducibility of coronary artery calcium scoring. , 2001, Radiology.